Sponsor:
Boston Children's Hospital
Code:
NCT02235623
Conditions
Unilateral Cryptorchidism
Eligibility Criteria
Sex: Male
Age: 0 - 3
Healthy Volunteers: Not accepted
Interventions
Single-stage Fowler-Stephens orchidopexy (FSO)
Two-stage Fowler-Stephens orchidopexy (FSO)
Brief summary:
Conditions
Unilateral Cryptorchidism
Study ID
NCT02235623
Start date
Aug, 2014
Status verified date
Apr, 2026
Completion date
Dec 31, 2030
Anticipated
Primary completion date
Dec 31, 2030
Anticipated
Eligibility Criteria
Sex: Male
Age: 0 - 3
Healthy Volunteers: Not accepted
Enrollment
66 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
other: Stage 1- Single-stage Fowler-Stephens orchidopexy (FSO)
other: Stage 2- Two-stage Fowler-Stephens orchidopexy (FSO)
Interventions
Single-stage Fowler-Stephens orchidopexy (FSO)
Two-stage Fowler-Stephens orchidopexy (FSO)
Primary outcome measure
Central contacts
Vera Rodic, MPH
Vera.Rodic@childrens.harvard.eduLocations
Boston Children's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Principal Investigator:
Caleb P Nelson, MD, MPH
Sponsor
Boston Children's Hospital
Last update posted
Apr 15, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2026-04-15.